Infections as Risk Factor of Sjögren’s Syndrome

References

• Patel R, Shahane A. The epidemiology of Sjögren’s syndrome. Clin Epidemiol. 2014;6:247–255.25114590
   PubMed Web of Science ®Google Scholar
• Foundation SsS. Sjögren’s syndrome fact sheet. Sjögren’s Syndrome Foundation; 2019.
   Google Scholar
• Manoussakis MN. Sjögren’s syndrome. Orphanet Ency. 2004.
   Google Scholar
• Kruszka P, O’brian R. Diagnosis and management of Sjögren syndrome. Am Fam Physician. 2009;79(6):465–470.19323359
   PubMed Web of Science ®Google Scholar
• Fox PC. Autoimmune diseases and Sjögren’s syndrome: an autoimmune exocrinopathy. Ann N Y Acad Sci. 2007;1098:15–21. doi:10.1196/annals.1384.00317332090
   PubMed Web of Science ®Google Scholar
• Segal B, Bowman S, Fox P, et al. Primary Sjögren’s syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes. 2009;7:46. doi:10.1186/1477-7525-7-4619473510
   PubMed Web of Science ®Google Scholar
• Somani R, Sunil M, Khaira J, Kumar D. Sjögren’s syndrome: a review. J Indian Acad Oral Med Radiol. 2011;23(1):61–64. doi:10.5005/jp-journals-10011-1094
   Google Scholar
• Baer A, Walitt B. Sjögren syndrome and other causes of sicca in the older adult. Clin Geriatr Med. 2017;33(1):87–103. doi:10.1016/j.cger.2016.08.00727886700
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by American-European consensus group. Ann Rheum Dis. 2002;61:554–558. doi:10.1136/ard.61.6.55412006334
   PubMed Web of Science ®Google Scholar
• Tsuboi H, Asashima H, Takai C. Primary and secondary surveys on epidemiology of Sjögren’s syndrome in Japan. Mod Rheumatol. 2014;24:464–470. doi:10.3109/14397595.2013.84376524252039
   PubMed Web of Science ®Google Scholar
• Vitali C, Del Papa N. Pain in primary Sjögren’s syndrome. Best Pract Res Clin Rheumatol. 2015;29:63–70. doi:10.1016/j.berh.2015.05.00226267000
   PubMed Web of Science ®Google Scholar
• Macfarlane G, Croft P, Schollum J, Silman A. Widespread pain: is an improved classification possible? J Rheumatol. 1996;23:1628–1632.8877936
   PubMed Web of Science ®Google Scholar
• Kassan S, Moutsopoulos H. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med. 2004;164:1275–1284. doi:10.1001/archinte.164.12.127515226160
   PubMed Web of Science ®Google Scholar
• Shiboski C, Shiboski S, Seror R, et al. 2016 ACR-EULAR classification for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheum. 2017;69(1):35–45. doi:10.1002/art.39859
   PubMed Web of Science ®Google Scholar
• Bayetto K, Logan R. Sjögren’s syndrome: a review of aetiology, pathogenesis, diagnosis and management. Aust Dent J. 2010;55:39–47. doi:10.1111/j.1834-7819.2010.01197.x20553243
   PubMed Web of Science ®Google Scholar
• Bach J-F. Infections and autoimmune diseases. J Autoimmun. 2005;25:74–80. doi:10.1016/j.jaut.2005.09.02416278064
   PubMed Web of Science ®Google Scholar
• Yamamoto K. Pathogenesis of Sjögren’s syndrome. Autoimmun Rev. 2003;2:13–18. doi:10.1016/S1568-9972(02)00121-012848970
   PubMed Web of Science ®Google Scholar
• Heward J, Gough S. Genetic susceptibility to the develoment of autoimmune disease. Clin Sci. 1997;93:479–491. doi:10.1042/cs0930479
   PubMed Web of Science ®Google Scholar
• Igoe A, Scofield R. Autoimmunity and infection in Sjögren’s syndrome. Curr Opin Immunol. 2013;25:480–487.
   Google Scholar
• Burns J. Persistent cytomegalovirus infection - the etiology of Sjögren’s syndrome. Med Hypotheses. 1983;10:451–460. doi:10.1016/0306-9877(83)90011-76308404
   PubMed Web of Science ®Google Scholar
• Duke R. Self recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens. J Exp Med. 1989;170:59–71. doi:10.1084/jem.170.1.592787386
   PubMed Web of Science ®Google Scholar
• Fujinami R, von Herrath M, Christen U, Whitton J. Molecular mimictry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev. 2006;19(1):80–94. doi:10.1128/CMR.19.1.80-94.200616418524
   PubMed Web of Science ®Google Scholar
• Tomlinson I, Bodmer W. The HLA system and the analysis of multifactorial genetic disease. Trends Genet. 1995;11:493–498. doi:10.1016/S0168-9525(00)89159-38533166
   PubMed Web of Science ®Google Scholar
• Fujinami R, Oldstone M. Amino acid homology between the ecephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 1985;230:1043–1045. doi:10.1126/science.24148482414848
   PubMed Web of Science ®Google Scholar
• Nakamura H, Shimizu T, Takagi Y, et al. Reevaluation for clinical manifestations of HTLV-1-seropositive parients with Sjögren’s syndrome. BMC Musculoskelet Disord. 2015;16(335). doi:10.1186/s12891-015-0773-1
   Web of Science ®Google Scholar
• Bureta C, Abematsu M, Tominaga H, et al. Hypertrophic spinal pachymeningitis associated with human T-cell lymphotrophic virus-1 infection and Sjögren’s syndrome: a case report and brief literature review. Int J Surg Case Rep. 2018;45:22–28. doi:10.1016/j.ijscr.2018.03.01029571060
   PubMed Web of Science ®Google Scholar
• Lima C, Santos S, Dourado A, et al. Association of sicca syndrome with proviral load and proinflammatory cytokines in HTLV-1 infection. J Immunol Res. 2016;2016. doi:10.1155/2016/8402059
   Web of Science ®Google Scholar
• Terada K, Katamine S, Eguchi K, et al. Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren’s syndrome. Lancet. 1994;344:1116–1119. doi:10.1016/S0140-6736(94)90630-07934493
   PubMed Web of Science ®Google Scholar
• Kivity S, Arango M, Ehrenfeld M, et al. Infection and autoimmunity in Sjögren’s syndrome: a clinical study and comprehensive review. J Autoimmun. 2014. doi:10.1016/j.jaut.2014.02.008
   Web of Science ®Google Scholar
• Pasoto S, Natalino R, Chakkour H, et al. EBV reactivation serological profile in primary Sjögren’s syndrome: an underlying trigger of active articular involvement? Rheumatol Int. 2013;33:1149–1157. doi:10.1007/s00296-012-2504-322955798
   PubMed Web of Science ®Google Scholar
• Nagata Y, Inoue H, Yamada K, et al. Activation of Epstein-Barr virus by saliva drom Sjögren’s syndrome patients. J Immunol. 2004;111:223–229. doi:10.1111/j.0019-2805.2003.01795.x
   Web of Science ®Google Scholar
• Inoue H, Mishima K, Yamamoto-Yoshida S, et al. Aryl hydrocarbon receptor-mediated induction of EBV reactivation as a risk factor for Sjögren’s syndrome. J Immunol. 2012;188:4654–4662. doi:10.4049/jimmunol.110157522467650
   PubMed Web of Science ®Google Scholar
• Sanosyan A, Daien C, Nutz A, et al. Discrepancy of serological and molecular patterns of circulating Epstein-Barr virus reactivation in primary Sjögren’s syndrome. Front Immunol. 2019;10:1153. doi:10.3389/fimmu.2019.0115331191532
   PubMed Web of Science ®Google Scholar
• Prunoiu C, Georgescu E, Georgescu M, Simionescu C. Sjögren’s syndrome associated with chronic hepatitis C – the benefit of the antiviral treatment. Rom J Morphol Embryol. 2008;49:557–562.19050807
   PubMed Web of Science ®Google Scholar
• Dinescu S, Ciurea P, Vreju F, Sandulescu D, Musetescu A. Hepatitis C virus induced Sjögren’s syndrome - clinical and imaging features. Curr Health Sci J. 2017;43:78–82.30595859
   PubMedGoogle Scholar
• Loustaud-Ratti V, Riche A, Liozon E, et al. Prevalence and characteristics of Sjögren’s syndrome or sicca syndrome in chronic hepatitis C virus infection: a prospective study. J Rheumatol. 2001;28:2245–2251.11669164
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, García-Carrasco M, Carvera R, et al. Th1/Th2 cytokine imbalance in patients with Sjögren’s syndrome secondary to hepatitis C virus infection. Semin Arthritis Rheum. 2002;32:56–63. doi:10.1053/sarh.2002.3372412219321
   PubMed Web of Science ®Google Scholar
• Fan X, Liu W, Li C, Wang Z, Luo L, Tan D. Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection. Mediators Inflamm. 1998;7:295–297. doi:10.1080/096293598909929792341
   PubMed Web of Science ®Google Scholar
• Fleck M, Kern E, Zhou T, Lang B, Mountz J. Murine cytomegalovirus induces a Sjögren’s syndrome-like disease in C57B1/6-lpr/lpr mice. Arthritis Rheum. 1998;41:2175–2184.9870874
   PubMed Web of Science ®Google Scholar
• Ohyama Y, Carroll V, Deshmukh U, Gaskin F, Brown M, Fu S. Severe focal sialadenitis and dacryoadenitis in NZM2328 mice induced by MCMV: a novel model for human Sjögren’s syndrome. J Immunol. 2006;177:7391. doi:10.4049/jimmunol.177.10.739117082658
   PubMed Web of Science ®Google Scholar
• Triantafyllopoulou A, Tapinos N, Moutsopoulos H. Evidence for Coxsackievir infection in primary Sjögren’s syndrome. Arthritis Rheum. 2004;50(9):2897–2902. doi:10.1002/art.2046315457458
   PubMed Web of Science ®Google Scholar
• Stathopoulou E, Routsias J, Stea E, Moutsopoulos H, Tzioufas A. Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and homologous peptide of Coxsackie virus 2B protein. Clin Exp Rheumatol. 2005;141:148–154.
   Google Scholar
• El Miedany Y, Baddour M, Ahmed I, Fahmy H. Sjögren’s syndrome: concomitant H. Pylori infection and possible correlation with clinical parameters. Joint Bone Spine. 2005;72:135–141. doi:10.1016/j.jbspin.2004.04.00515797493
   PubMed Web of Science ®Google Scholar
• De Vita S, Ferraccioli G, Avellini C, et al. WIdespread clonal B-cell disorder in Sjögren’s syndrome predisposing to Heliobacter pylori – related gastric lymphoma. Gastroenterology. 1996;110:1969–1974. doi:10.1053/gast.1996.v110.pm89644258964425
   PubMed Web of Science ®Google Scholar
• Sughimoto K, Nakano K, Gomi A, Nakatani H, Nakamura Y, Sato A. Infective endocarditis associated with Sjögren’s syndrome. Asian Cardiovasc Thorac Ann. 2006;14:115–117. doi:10.1177/021849230601400629
   Google Scholar
• Fabris M, Dolcetti R, Pasini E, et al. High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren’s syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type. Clin Exp Rheumatol. 2014;32:61–65.24447326
   PubMed Web of Science ®Google Scholar
• Mariette X, Gozlan J, Clerc D, Bisson M, Morinet F. Reactivation of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren’s syndrome. Am J Med. 1991;90:286–294. doi:10.1016/0002-9343(91)80007-91848394
   PubMed Web of Science ®Google Scholar
• Agmon-Levin N, Lian Z, Shoenfeld Y. Explosion of autoimmune diseases and the mosaic of old and novel factors. Cell Mol Immunol. 2011;8:189–192. doi:10.1038/cmi.2010.7021358666
   PubMed Web of Science ®Google Scholar
• Hemmer B, Fleckenstein B, Vergelli M, et al. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T-cell clone. J Exp Med. 1997;185:1651–1659. doi:10.1084/jem.185.9.16519151902
   PubMed Web of Science ®Google Scholar
• Smyth M, Sedgwick JD. Delayed kinetics of tumor decrosis factor-mediated bystander lysis by peptide-specific CD8+ cytotoxic T lymphocytes. Eur J Immunol. 1998;28:4162–4169.9862352
   PubMed Web of Science ®Google Scholar
• Yasukawa M, Yakushijin Y, Hasegawa H, et al. Expression of perforin and membrane-bouncd lymphotoxin (tumor necrosis factor-beta) in virus-specific CD4+ human cytotoxic T-cell clones. Blood. 1993;81:1527–1534. doi:10.1182/blood.V81.6.1527.15278095828
   PubMed Web of Science ®Google Scholar
• Narkeviciute I, Sudzius G, Mieliauskaite D, et al. Are cytotoxic effector cells changes in peripheral blood of patients with Sjögren’s syndrome related to persistent virus infection: suggestions and conundrums. Cell Immunol. 2016;310:123–130. doi:10.1016/j.cellimm.2016.08.01327592028
   PubMed Web of Science ®Google Scholar
• Pacheco Y, Acosta-Ampudia Y, Monsalve D, Chang C, Gershwin M, Anaya J. Bystander activation and autoimmunity. J Autoimmun. 2019;103:102301. doi:10.1016/j.jaut.2019.06.01231326230
   PubMed Web of Science ®Google Scholar
• Manthorpe R, Morling N, Platz P, Ryder L, Svejgaard A, Thomsen M. HLA-D antigen frequencies in Sjögren’s syndrome: differences between the primary and secondary form. Scand J Rheumatol. 1981;10:124–128. doi:10.3109/030097481090952846941466
   PubMed Web of Science ®Google Scholar
• Fox R, Luppi M, Kang H, Pisa P. Reactivation of Epstein-Barr virus in Sjögren’s syndrome. Springer Semin Immunopathol. 1991;13:217–231. doi:10.1007/BF002014701664987
   PubMed Web of Science ®Google Scholar
• Cojocaru M, Cojocaru I, Silosi I. Autoimmune diseases and their environmental triggers. Maedica-J Clin Med. 2008;3(2):124–129.
   Google Scholar
• Singh S, Wal P, Wal A, Srivastava V, Tiwari R, Sharma R. Understanding autoimmune disease: an update review. Int J Pharm Technol Biotechnol. 2016;3(3):51–65.
   Google Scholar
• Nakamura H, Shimizu T, Kawakami A. Role of viral infections in the pathogenesis of Sjögren’s syndrome: different characteristics of Epstein-Barr virus and HTLV-1. J Clin Med. 2020;9:1459. doi:10.3390/jcm9051459
   Web of Science ®Google Scholar
• Bolstad A, Jonsson R. Genetic aspects of Sjögren’s syndrome. Arthritis Res. 2002;4:353–359. doi:10.1186/ar59912453311
   PubMedGoogle Scholar
• Bolstad A, Wassmuth R, Haga H, Jonsson R. HLA markers and clinical characteristics in Caucasians with primary Sjögren’s syndrome. J Rheumatol. 2001;28:1554–1562.11469461
   PubMed Web of Science ®Google Scholar
• Nakken B, Jonsson R, Brokstad K, et al. Associations of MHC class II alleles in Norwegian primary Sjögren’s syndrome patients: implications for development of autoantibodies to the Ro52 autoantigen. Scand J Rheumatol. 2001;54:428–433.
   Google Scholar
• Nepom G. MHC and autoimmune diseases. Immunol Ser. 1993;59:143–164.8461386
   PubMedGoogle Scholar
• Papasteriades C, Skopouli F, Drosos A, Andonopoulos A, Moutsopoulos H. HLA-alloantigen associations in Greek patients with Sjögren’s syndrome. J Autoimmun. 1988;1:85–90. doi:10.1016/0896-8411(88)90079-03151145
   PubMed Web of Science ®Google Scholar
• Miyagawa S, Shinohara K, Nakajima M, et al. Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects. Arthritis Rheum. 1998;41:927–934.9588746
   PubMed Web of Science ®Google Scholar
• Priori R, Medda E, Conti F, et al. Risk factors for Sjögren’s syndrome: a case-control study. Clin Exp Rheumatol. 2007;25:378–384.17631733
   PubMed Web of Science ®Google Scholar